Clearside Biomedical Inc (CLSD)
1.30
+0.04
(+3.17%)
USD |
NASDAQ |
May 02, 16:00
1.30
0.00 (0.00%)
After-Hours: 18:48
Clearside Biomedical Net Income (TTM): -32.48M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -32.48M |
September 30, 2023 | -37.32M |
June 30, 2023 | -35.88M |
March 31, 2023 | -34.58M |
December 31, 2022 | -32.95M |
September 30, 2022 | -4.575M |
June 30, 2022 | -1.635M |
March 31, 2022 | 0.083M |
December 31, 2021 | 0.376M |
September 30, 2021 | -25.44M |
June 30, 2021 | -22.99M |
March 31, 2021 | -22.65M |
December 31, 2020 | -18.21M |
September 30, 2020 | -14.19M |
June 30, 2020 | -18.30M |
March 31, 2020 | -18.28M |
December 31, 2019 | -30.77M |
Date | Value |
---|---|
September 30, 2019 | -49.31M |
June 30, 2019 | -66.65M |
March 31, 2019 | -81.62M |
December 31, 2018 | -82.82M |
September 30, 2018 | -77.67M |
June 30, 2018 | -72.14M |
March 31, 2018 | -65.21M |
December 31, 2017 | -58.98M |
September 30, 2017 | -52.17M |
June 30, 2017 | -39.48M |
March 31, 2017 | -30.81M |
December 31, 2016 | -25.88M |
September 30, 2016 | -21.37M |
June 30, 2016 | -19.20M |
March 31, 2016 | -19.33M |
December 31, 2015 | -17.64M |
September 30, 2015 | -15.13M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-66.65M
Minimum
Jun 2019
0.376M
Maximum
Dec 2021
-24.51M
Average
-22.99M
Median
Jun 2021
Net Income (TTM) Benchmarks
Cassava Sciences Inc | -97.22M |
Heron Therapeutics Inc | -110.56M |
Actinium Pharmaceuticals Inc | -46.45M |
Karyopharm Therapeutics Inc | -143.10M |
Ocular Therapeutix Inc | -80.74M |